Literature DB >> 6149804

The 12th J. A. F. Stevenson memorial lecture. Aging, Alzheimer's disease, and the cholinergic system.

P L McGeer.   

Abstract

Aging does not affect tissues in a uniform fashion. Within the brain, substantial neuronal dropout occurs with age in the cholinergic medial basal forebrain complex, the noradrenergic locus coeruleus, and the dopaminergic substantia nigra pars compacta. These areas are also struck by diseases that are sharply age dependent. Alzheimer's disease causes neuronal destruction in the cholinergic cells of the medial basal forebrain and noradrenergic cells of the locus coeruleus. Parkinson's disease causes neuronal destruction mainly in the substantia nigra but with some destruction in the locus coeruleus. Parkinsonism-dementia affects all three areas. Alzheimer's disease is responsible for 50-60% of all cases of dementia. Severe dementia rises in frequency from less than 1% of the population at age 65-70 to over 15% by age 85. The cause of the disease is unknown. No method of prevention is known and present treatments are ineffective, although modest improvement has been reported for various therapeutic regimens designed to stimulate the cholinergic system. The neuronal systems identified as being affected in Alzheimer's disease and in the dementia of Parkinsonism correspond with those shown many years ago to be associated with the reticular activating system. This correspondence permits a new hypothesis of cognition and memory to be put forward, as well as a reinterpretation of data from animal research on the reticular activating system performed over a quarter of a century ago. The locus coeruleus is proposed as the noradrenergic element sensitizing the cortex to conscious recognition of real time events. The medial basal forebrain complex is proposed as the system registering the conscious event for storage and as the readout device when it is subsequently redisplayed in the cortex as memory. Storage could either be in the temporal lobe, in several areas of cortex with feedback to the medial basal forebrain, or in the cholinergic cells themselves.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149804     DOI: 10.1139/y84-123

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  8 in total

1.  Herpes simplex virus: a role in the aetiology of Alzheimer's disease?

Authors:  G W Roberts; G R Taylor; G I Carter; J A Johnson; C Bloxham; R Brown; T J Crow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

2.  Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level.

Authors:  L Nilsson; A Nordberg; J Hardy; P Wester; B Winblad
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 3.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

4.  In vitro effect of aluminum chloride on choline acetyltransferase activity of the rat brain during postnatal growth.

Authors:  G Cherroret; D Desor; P R Lehr
Journal:  Bull Environ Contam Toxicol       Date:  1994-04       Impact factor: 2.151

Review 5.  Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release.

Authors:  R Quirion
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

6.  Modulation of the reaction of hippocampal neurons to sensory stimuli by cholinergic substances.

Authors:  O S Vinogradova; E S Brazhnik; V F Kichigina; V S Stafekhina
Journal:  Neurosci Behav Physiol       Date:  1996 Mar-Apr

7.  In Vivo Differences between Two Optical Isomers of Radioiodinated o-iodo-trans-decalinvesamicol for Use as a Radioligand for the Vesicular Acetylcholine Transporter.

Authors:  Izumi Uno; Takashi Kozaka; Daisuke Miwa; Yoji Kitamura; Mohammad Anwar-Ul Azim; Kazuma Ogawa; Junichi Taki; Seigo Kinuya; Kazuhiro Shiba
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 8.  In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents.

Authors:  Kazuma Ogawa; Kazuhiro Shiba
Journal:  Contrast Media Mol Imaging       Date:  2018-06-13       Impact factor: 3.161

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.